Concepedia

Publication | Closed Access

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft

34

Citations

42

References

2008

Year

References

YearCitations

Page 1